cidofovir anhydrous has been researched along with Alastrim in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 19 (65.52) | 29.6817 |
2010's | 4 (13.79) | 24.3611 |
2020's | 6 (20.69) | 2.80 |
Authors | Studies |
---|---|
Forthal, DN; Henry, BM; Lippi, G; Rizk, JG; Rizk, Y | 1 |
Chiu, CW; Hsueh, PR; Hung, YP; Ko, WC; Lee, CC; Lee, JC | 1 |
Afraie, M; Gilzad-Kohan, H; Khateri, S; Mahdavi Mortazavi, SM; Moradi, Y; Nasseri, S; Soheili, M | 1 |
Aldhafeeri, AA; Alharbi, AS; Allahyani, M; Almehmadi, M; Alotaibi, AN; Alotaibi, SS; Alsaiari, AA; Alshammari, MK; Alsubaihi, LI; Hussain, KH; Imran, M; Kamal, M | 1 |
Jung, J; Kim, SB; Peck, KR | 1 |
Begum, JPS; Gupta, A; Ngangom, L; Painuli, S; Semwal, P; Sharma, R | 1 |
Damon, IK; Foster, S; Gates, I; Lanier, ER; Li, Y; Olson, VA; Smith, SK; Trost, LC | 1 |
de Alencastro, RB; de Souza, FR; França, TC; Gonçalves, AS; Guimarães, AP; Oliveira, AA; Ramalho, TC | 1 |
Foster, SA; Godin, SJ; Keilholz, L; Khouri, J; Long, J; Rose, ML; Trost, LC | 1 |
Arndt, W; Damon, IK; Denzler, KL; Jacobs, BL; Langland, JO; Mitnik, C; Olson, VA; Rochon, Y; Waters, R; White, S | 1 |
McConnell, J | 1 |
Eckerman, NL; Roos, KL | 1 |
Elgh, F; Tegnell, A; Wahren, B | 1 |
De Clercq, E; Neyts, J | 1 |
Sidwell, RW; Smee, DF | 1 |
Blauvelt, A; Sanchez, S; Toro, JR; Turiansky, G | 1 |
Check, E | 2 |
Blair, DC; Guharoy, R; Krenzelok, EP; Noviasky, JA; Panzik, R | 1 |
Bray, M; Roy, CJ | 1 |
Shinzato, T | 1 |
Garrison, A; Goff, A; Lawler, J; Mucker, E; Paragas, J; Twenhafel, N | 1 |
Adams, MM; Moyer, RW; Rice, AD | 1 |
Bray, M; Huggins, JW; Kefauver, D; Martinez, M; Smee, DF; Thompson, E | 1 |
Cohen, J | 1 |
Bradbury, J | 1 |
Evans, M; Ridings, H | 1 |
Morris, K | 1 |
11 review(s) available for cidofovir anhydrous and Alastrim
Article | Year |
---|---|
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments.
Topics: Animals; Cidofovir; DNA; Humans; Mpox (monkeypox); Smallpox; United States; Vaccines | 2022 |
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
Topics: Animals; Antiviral Agents; Cidofovir; COVID-19; Disease Outbreaks; Immunoglobulin A, Secretory; Monkeypox virus; Mpox (monkeypox); Orthopoxvirus; Rabbits; Smallpox; United States; Variola virus | 2022 |
Monkeypox: the resurgence of forgotten things.
Topics: Animals; Cidofovir; Disease Outbreaks; Humans; Monkeypox virus; Mpox (monkeypox); Smallpox | 2022 |
Emergence of monkeypox: a worldwide public health crisis.
Topics: Animals; Cidofovir; Global Health; Humans; Mpox (monkeypox); Public Health; Smallpox; Vaccination | 2023 |
Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; History, 20th Century; Humans; Organophosphonates; Organophosphorus Compounds; Poxviridae Infections; Smallpox; Time Factors; Vaccinia | 2003 |
A review of compounds exhibiting anti-orthopoxvirus activity in animal models.
Topics: Animals; Antiviral Agents; Bioterrorism; Cidofovir; Cytosine; Disease Models, Animal; Humans; Mice; Mice, SCID; Nucleosides; Organophosphonates; Organophosphorus Compounds; Orthopoxvirus; Poxviridae Infections; Rabbits; Smallpox; Thiosemicarbazones | 2003 |
Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
Topics: Administration, Cutaneous; Administration, Topical; Antiviral Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Infectious; Skin Neoplasms; Smallpox; Warts | 2003 |
Smallpox: clinical features, prevention, and management.
Topics: Antiviral Agents; Bioterrorism; Cidofovir; Cytosine; Female; Humans; Infant; Male; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine | 2004 |
Antiviral prophylaxis of smallpox.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; Vaccination | 2004 |
[Smallpox].
Topics: Animals; Antiviral Agents; Bioterrorism; Cidofovir; Cytosine; Diagnosis, Differential; Humans; Organophosphonates; Polymerase Chain Reaction; Smallpox; Smallpox Vaccine; Vaccines, Attenuated; Variola virus | 2004 |
Understanding the threat of smallpox.
Topics: Bioterrorism; Cidofovir; Cytosine; Diagnosis, Differential; Humans; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; United States | 2002 |
18 other study(ies) available for cidofovir anhydrous and Alastrim
Article | Year |
---|---|
Prevention and Treatment of Monkeypox.
Topics: Animals; Antiviral Agents; Child; Cidofovir; Female; Humans; Mpox (monkeypox); Pregnancy; Smallpox; Vaccinia virus | 2022 |
A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.
Topics: Antiviral Agents; Cidofovir; Humans; Lipids; Monkeypox virus; Mpox (monkeypox); Smallpox | 2022 |
In vitro efficacy of brincidofovir against variola virus.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Organophosphonates; Smallpox; Variola virus | 2014 |
Design of inhibitors of thymidylate kinase from Variola virus as new selective drugs against smallpox.
Topics: Acyclovir; Antiviral Agents; Catalytic Domain; Cidofovir; Cytosine; Drug Design; Humans; Kinetics; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Nucleoside-Phosphate Kinase; Organophosphonates; Small Molecule Libraries; Smallpox; Species Specificity; Structure-Activity Relationship; Thermodynamics; Variola virus; Viral Proteins | 2015 |
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Injections, Intradermal; Organophosphonates; Rabbits; Random Allocation; Smallpox; Vaccinia; Vaccinia virus; Variola virus | 2015 |
In vitro characterization of a nineteenth-century therapy for smallpox.
Topics: Animals; Canada; Cell Line; Cidofovir; Cytosine; Fluorescent Antibody Technique; HeLa Cells; History, 19th Century; Humans; In Vitro Techniques; Organophosphonates; Phytotherapy; Plant Extracts; Rabbits; Real-Time Polymerase Chain Reaction; Sarraceniaceae; Smallpox; United States; Variola virus; Virus Replication | 2012 |
Gearing up for smallpox.
Topics: Animals; Antiviral Agents; Bioterrorism; Cidofovir; Cytosine; Humans; Macaca fascicularis; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; United States; Variola virus | 2002 |
The smallpox vaccine and postvaccinal encephalitis.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Bioterrorism; Cidofovir; Contraindications; Cytosine; Encephalomyelitis, Acute Disseminated; Female; gamma-Globulins; History, 19th Century; History, 20th Century; Humans; Male; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; Vaccination | 2002 |
Smallpox--eradicated, but a growing terror threat.
Topics: Antiviral Agents; Biological Warfare; Bioterrorism; Cidofovir; Cytosine; Europe; History, 16th Century; History, 18th Century; History, 20th Century; History, Ancient; History, Medieval; Humans; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; USSR | 2002 |
Boom, or bust?
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Animals; Bacterial Vaccines; Biomedical Research; Bioterrorism; Cidofovir; Cytosine; Federal Government; Humans; Influenza Vaccines; Organophosphonates; Organophosphorus Compounds; Research Personnel; Research Support as Topic; Smallpox; United States | 2003 |
Unanimous vote approves tweak to smallpox genome.
Topics: Cidofovir; Cytosine; Drug Evaluation, Preclinical; Genes, Reporter; Genetic Engineering; Genome, Viral; Humans; Organophosphonates; Smallpox; Smallpox Vaccine; Variola virus; World Health Organization | 2004 |
In vivo imaging of cidofovir treatment of cowpox virus infection.
Topics: Animals; Antiviral Agents; Bioterrorism; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; DNA Replication; Drug Evaluation, Preclinical; Female; Green Fluorescent Proteins; Humans; Image Processing, Computer-Assisted; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Organophosphonates; Recombination, Genetic; Smallpox; Treatment Outcome; Vero Cells; Virus Replication | 2007 |
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Organophosphonates; Poxviridae Infections; Rabbits; Smallpox; Survival Rate; Vaccinia; Vaccinia virus; Viremia | 2007 |
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
Topics: Administration, Intranasal; Aerosols; Animals; Antiviral Agents; Bronchi; Cidofovir; Cowpox; Cytosine; Female; Hemorrhage; Mice; Mice, Inbred BALB C; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pulmonary Alveoli; Smallpox; Vaccination | 2000 |
Bioterrorism. Blocking smallpox: a second defense.
Topics: Animals; Antiviral Agents; Bioterrorism; Cidofovir; Cytosine; Disease Models, Animal; Disease Outbreaks; Humans; Macaca fascicularis; Military Medicine; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; United States; Variola virus; World Health Organization | 2001 |
Smallpox eradication: destruction of variola virus stocks.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Humans; Macaca fascicularis; Mice; Models, Animal; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Public Health; Sequence Analysis, DNA; Smallpox; Smallpox Vaccine; Variola virus; World Health Organization | 2002 |
Orally available cidofovir derivative active against smallpox.
Topics: Administration, Oral; Cidofovir; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds; Smallpox | 2002 |
Oral drug and old vaccine renew smallpox bioterror debate.
Topics: Animals; Antiviral Agents; Bioterrorism; Cidofovir; Contraindications; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; United States | 2002 |